Crinetics (CRNX) grants RSUs and stock options to board director
Rhea-AI Filing Summary
Crinetics Pharmaceuticals director Caren Deardorf received new equity awards in the form of restricted stock units and stock options. She was granted 5,925 restricted stock units, representing the right to receive the same number of common shares, which vest 100% on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, subject to her continued board service.
She was also granted stock options covering 9,730 shares of common stock at an exercise price of $35.87 per share, expiring on June 18, 2036, with the same vesting schedule. Following these awards, she directly holds 22,225 shares of common stock, in addition to the new option position.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 9,730 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 5,925 | $0.00 | $0.00 |
Footnotes (2)
- F1. The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
- F2. The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
Key Figures
Key Terms
restricted stock units financial
stock option financial
vest financial
exercise price financial
FAQ
What equity awards did Caren Deardorf receive from Crinetics (CRNX)?
When do Caren Deardorf’s new Crinetics (CRNX) awards vest?
What is the exercise price and term of Caren Deardorf’s Crinetics stock options?
Are Caren Deardorf’s new Crinetics awards open-market purchases or compensation grants?
AI-generated analysis. How Rhea-AI works. Not financial advice.